<html>
<head>PUBMED IDs for ARHGEF3</head>
<body bgcolor='#C5F0F2'><h1>ARHGEF3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10873612/'>Isolation of two novel human RhoGEFs, ARHGEF3 and ARHGEF4, in 3p13-21 and 2q22.</a> June 30  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/18499081/'>Identification of a role for the ARHGEF3 gene in postmenopausal osteoporosis.</a> May 24  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19427924/'>Further genetic evidence suggesting a role for the RhoGTPase-RhoGEF pathway in osteoporosis.</a> September 3  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19727905/'>Common variants in FLNB/CRTAP, not ARHGEF3 at 3p, are associated with osteoporosis in southern Chinese women.</a> March 30  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/21715309/'>Silencing of RhoA nucleotide exchange factor, ARHGEF3, reveals its unexpected role in iron uptake.</a> January 10  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23263863/'>GWAS of blood cell traits identifies novel associated loci and epistatic interactions in Caucasian and African-American children.</a> August 29  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23625948/'>The nuclear factor κB family member RelB facilitates apoptosis of renal epithelial cells caused by cisplatin/tumor necrosis factor α synergy by suppressing an epithelial to mesenchymal transition-like phenotypic switch.</a> September 12  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24488012/'>Next-generation sequencing reveals novel rare fusion events with functional implication in prostate cancer.</a> April 11  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24840563/'>Influence of ARHGEF3 and RHOA knockdown on ACTA2 and other genes in osteoblasts and osteoclasts.</a> January 13  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26267680/'>[Screening and functional analysis of microRNA expression in HPV16-positive squamous carcinoma of the cervix  in the Uygur of southern Xinjiang].</a> October 8  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27028992/'>The putative tumor activator ARHGEF3 promotes nasopharyngeal carcinoma cell pathogenesis by inhibiting cellular apoptosis.</a> March 31  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27028920/'>Genetic Targeting of the Albumin Locus to Treat Hemophilia.</a> April 10  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28146080/'>Whole Exome Sequencing in Psoriasis Patients Contributes to Studies of Acitretin Treatment Difference.</a> April 21  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28289279/'>Next-gen sequencing identifies non-coding variation disrupting miRNA-binding sites in neurological disorders.</a> March 16  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28542600/'>SNP in human ARHGEF3 promoter is associated with DNase hypersensitivity, transcript level and platelet function, and Arhgef3 KO mice have increased mean platelet volume.</a> May 26  2017<br></body></html>
